Iktos and Teijin Pharma to Co-Develop New Technology for Small Molecule Drug Discovery

Author's Avatar
Apr 05, 2022

Iktos, a company specialized in Artificial Intelligence (AI) for new drug design, and Teijin+Pharma+Limited, the core company of the Teijin+Group’s healthcare business that provides comprehensive healthcare services to improve the quality of life, today announced a strategic collaboration agreement in Artificial Intelligence for new drug design.